Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 163

Similar articles for PubMed (Select 22472291)

2.

Canada's implementation of the Paragraph 6 Decision: is it sustainable public policy?

Cohen-Kohler JC, Esmail LC, Cosio AP.

Global Health. 2007 Dec 6;3:12.

3.

Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime.

Esmail LC, Phillips K, Kuek V, Cosio AP, Kohler JC.

BMC Int Health Hum Rights. 2010 Jan 4;10:1. doi: 10.1186/1472-698X-10-1.

4.
5.

Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?

Oliveira MA, Bermudez JA, Chaves GC, Velásquez G.

Bull World Health Organ. 2004 Nov;82(11):815-21. Epub 2004 Dec 14.

6.

Canada and access to medicines in developing countries: intellectual property rights first.

Lexchin J.

Global Health. 2013 Sep 3;9:42. doi: 10.1186/1744-8603-9-42.

8.

Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?

Dionisio D, Cao Y, Hongzhou L, Kraisintu K, Messeri D.

Curr HIV Res. 2006 Jan;4(1):3-20. Review.

PMID:
16454707
9.

[Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].

Chaves GC, Oliveira MA, Hasenclever L, de Melo LM.

Cad Saude Publica. 2007 Feb;23(2):257-67. Review. Portuguese.

10.

Access to medicines and domestic compulsory licensing: learning from Canada and Thailand.

Kuek V, Phillips K, Kohler JC.

Glob Public Health. 2011;6(2):111-24. doi: 10.1080/17441690903575255.

PMID:
20234967
12.

Panel: Canada's law on global access to affordable medicines.

Avafia T, Morrison C, Clark B, Kohler JC.

HIV AIDS Policy Law Rev. 2009 Dec;14(2):76-83.

PMID:
20225526
13.

Removing barriers? An overview of the Canadian Access to Medicines Regime.

Penner MD, Armstrong PG.

Health Law Can. 2008 Jun;28(3-4):112-22.

PMID:
19051971
15.

Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?

Ooms G, Forman L, Williams OD, Hill PS.

BMC Int Health Hum Rights. 2014 Dec 18;14:37. doi: 10.1186/s12914-014-0037-4.

16.

Compulsory patent licensing and local drug manufacturing capacity in Africa.

Owoeye OA.

Bull World Health Organ. 2014 Mar 1;92(3):214-9. doi: 10.2471/BLT.13.128413. Epub 2014 Jan 10.

17.

What strategies to boost production of affordable fixed-dose anti-retroviral drug combinations for children in the developing world?

Dionisio D, Gass R, McDermott P, Racalbuto V, Madeo M, Braghieri G, Crowley S, Pinheiro Edos S, Graaff P, Vasan A, Eksaengsri A, Moller H, Khanna AK, Kraisintu K, Juneja S, Nicolaou S, Sengupta A, Esperti F, Messeri D.

Curr HIV Res. 2007 Mar;5(2):155-87.

PMID:
17346132
18.

Compulsory licensing in Canada and Thailand: comparing regimes to ensure legitimate use of the WTO rules.

Lybecker KM, Fowler E.

J Law Med Ethics. 2009 Summer;37(2):222-39. doi: 10.1111/j.1748-720X.2009.00367.x.

PMID:
19493068
19.

WTO approves TRIPS amendment on importing under compulsory licensing.

Herget G.

HIV AIDS Policy Law Rev. 2006 Apr;11(1):23-4.

PMID:
16805011
20.

Canada's Access to Medicines Regime: Promise or Failure of Humanitarian Effort?

Kohler JC, Lexchin J, Kuek V, Orbinski J.

Healthc Policy. 2010 Feb;5(3):40-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk